Answers are grounded in this paper and cite their sources.
The pathophysiology of COVID-19 is an enigma with its severity often determined by the extent of coagulopathy. Several regulatory pathways targeted by the SARS-CoV-2 include the renin-angiotensin system, von Willebrand Factor, and most importantly, the complement pathway. This article discusses these pathways to help design potential future therapies.
No takes yet. Share an insight, caveat, or question.
Rajan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: